Organization: Univ of Montreal

G7 Science Summit examines repercussions stemming from tsunami of new digital technologies

Canada’s hosting of this year’s G7 Summit is being preceded by an unprecedented series of research summits that examine the potential and impacts of digital technologies and sustainable oceans. The summits – organized by the Royal Society of Canada (RSC) – are intended to inform discussion at the main event in Charlevoix, QC on June 8-9.

RBC steps up investments in AI with new Montreal lab

Montreal has attracted two Canadian financial institutions to its emerging artificial intelligence (AI) cluster. The Royal Bank of Canada has announced more investments in AI research with a new AI lab to open in the city. It also announced a joint, $4-million investment with Bank of Montreal for the Creative Destruction Lab, also in Montreal.…

IRIC opens new labs, begins Phase II clinical trials

The Institute for Research in Immunology and Cancer (IRIC) has opened new laboratories for its medicinal core facility that will increase drug discovery capacity and accelerate the expansion of its chemical compounds library with the installation of a robotics suite. Located at the Univ of Montreal, IRIC’s new labs are a partnership with the university’s…

Microsoft Ventures invests in Montreal AI expertise

Microsoft Venture‘s new start-up fund has made its first investment in Element AI, a Montreal-based artificial intelligence start-up affiliated with researchers at McGill Univ, Univ of Montreal and Univ of Toronto. Founded by Dr Yoshua Bengio and serial entrepreneurs Jean-François Gagné and Nicolas Chapados, Element AI will use the undisclosed Microsoft investment to achieve scale…

University research funding drops first time in 14 years

University sponsored research income fell for the first time in 14 years, with the Top 50 institutions dropping 1.6% to $6.67 billion, according to the latest data from Research Infosource. Perennially top-ranked Univ of Toronto declined 6.2% to $1.04 billion, while the Univ of Montreal rose 4% to $548.8 million to claim the number two…

CIHR funds national hepatitis research network

The Canadian Institutes of Health Research has awarded $4.4 million for a new national network aimed at improving the health of people infected with hepatitis C and preventing new infections. The National Collaborative Hepatitis C Network has a team of 60 researchers led by Dr Naglaa Shoukry, a scientist at the Centre Hospitalier de l’Université…

Spin-off targets new market for stem cells

A new Montreal biotech company has been launched to commercialize a technology that would overcome the shortage of bone marrow donors for patients with acute myeloid leukemia. Launched by the Institute for Research in Immunology and Cancer – Commercialization of Research and the Centre for Commercialization of Regenerative Medicine, ExCellThera is based on a proprietary…

NSERC Discovery Frontiers short list announced

The Natural Sciences and Engineering Research Council (NSERC) has released a short list of six proposals for its Discovery Frontiers competition. The fund provides $1 million annually over four years to successful applicants. Projects submitting full proposals are: New Materials for Clean Energy and Enhanced Energy Efficiency from Heavy Oil and Oil Sands Reservoirs (Univ…

NSERC Discovery Frontiers short list announced

The Natural Sciences and Engineering Research Council (NSERC) has released a short list of six proposals for its Discovery Frontiers competition. The fund provides $1 million annually over four years to successful applicants. Projects submitting full proposals are: New Materials for Clean Energy and Enhanced Energy Efficiency from Heavy Oil and Oil Sands Reservoirs (Univ…

U of M and BMS announce research breakthrough

The Univ of Montreal has announced a major breakthrough in its collaboration with Bristol-Myers Squibb (BMS), New York NY. A team of scientists from BMS and the Institute of Research in Immunology and Cancer (IRIC) are launching clinical trials for a new jointly discovered small molecule drug candidate acting on a novel therapeutic agent, triggering…